Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats

Bo Yin,*,1 Dan-Dong Li,*,2,3 Shang-Yu Xu,3 Huan Huang,4 Jian Lin,3 Han-Song Sheng,3 Jun-Hao Fang,3 Jin-Ning Song,2 Ming Zhang11Department of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China; 2Departm...

Full description

Bibliographic Details
Main Authors: Yin B, Li DD, Xu SY, Huang H, Lin J, Sheng HS, Fang JH, Song JN, Zhang M
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/simvastatin-pretreatment-ameliorates-t-pandashinduced-hemorrhage-trans-peer-reviewed-article-NDT
_version_ 1818570798781169664
author Yin B
Li DD
Xu SY
Huang H
Lin J
Sheng HS
Fang JH
Song JN
Zhang M
author_facet Yin B
Li DD
Xu SY
Huang H
Lin J
Sheng HS
Fang JH
Song JN
Zhang M
author_sort Yin B
collection DOAJ
description Bo Yin,*,1 Dan-Dong Li,*,2,3 Shang-Yu Xu,3 Huan Huang,4 Jian Lin,3 Han-Song Sheng,3 Jun-Hao Fang,3 Jin-Ning Song,2 Ming Zhang11Department of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China; 2Department of Neurosurgery, The First Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 3Department of Neurosurgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 4Department of Radiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workBackground: The use of thrombolysis with tissue-plasminogen activator (t-PA) in patients with acute ischemic stroke (AIS) is limited by increased levels of matrix metalloproteinase-9 (MMP-9) and by the increased risk of hemorrhagic transformation (HT). In this study, we investigated the effects of simvastatin pretreatment on t-PA-induced MMP-9/tissue inhibitor of metalloproteinase-1 (TIMP-1) imbalance and HT aggravation in a rat AIS model.Methods: The rat AIS model was established by autologous blood emboli. Two weeks before surgery, rats were pretreated with simvastatin (60 mg/kg/d), and three hours after surgery, t-PA (10 mg/kg) was administered. MMP-9 and TIMP-1 levels in the infarcted zone and plasma were evaluated by Western blot analysis and ELISA; the level of HT was quantified by determining the hemoglobin content. RhoA activation was determined to clarify the potential effect.Results: The results suggested that pretreatment with simvastatin suppressed the increase in t-PA-induced MMP-9 levels and neutralized the elevated MMP-9/TIMP-1 ratio, but had no effect on TIMP-1 levels. Thrombolysis with t-PA after ischemia improved neurological outcome, but increased intracranial hemorrhage. Moreover, t-PA-induced HT aggravation was reduced by simvastatin pretreatment. In addition, we showed that t-PA-induced activation of RhoA was suppressed by simvastatin, and that t-PA-induced MMP-9/TIMP-1 imbalance and hemorrhage was reduced by Rho kinases (ROCK) inhibitor Y-27632.Conclusion: In this study, we showed that simvastatin pretreatment ameliorated t-PA-induced HT and MMP-9/TIMP-1 imbalance, and demonstrated that the RhoA/ROCK pathway was implicated.Keywords: simvastatin, acute ischemic stroke, t-PA, MMP-9/TIMP-1, RhoA/ROCK pathway, hemorrhagic transformation
first_indexed 2024-12-14T13:46:38Z
format Article
id doaj.art-e7128b6ea75442bf828d20277904a650
institution Directory Open Access Journal
issn 1178-2021
language English
last_indexed 2024-12-14T13:46:38Z
publishDate 2019-07-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj.art-e7128b6ea75442bf828d20277904a6502022-12-21T22:59:18ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212019-07-01Volume 151993200247149Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic ratsYin BLi DDXu SYHuang HLin JSheng HSFang JHSong JNZhang MBo Yin,*,1 Dan-Dong Li,*,2,3 Shang-Yu Xu,3 Huan Huang,4 Jian Lin,3 Han-Song Sheng,3 Jun-Hao Fang,3 Jin-Ning Song,2 Ming Zhang11Department of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China; 2Department of Neurosurgery, The First Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 3Department of Neurosurgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 4Department of Radiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workBackground: The use of thrombolysis with tissue-plasminogen activator (t-PA) in patients with acute ischemic stroke (AIS) is limited by increased levels of matrix metalloproteinase-9 (MMP-9) and by the increased risk of hemorrhagic transformation (HT). In this study, we investigated the effects of simvastatin pretreatment on t-PA-induced MMP-9/tissue inhibitor of metalloproteinase-1 (TIMP-1) imbalance and HT aggravation in a rat AIS model.Methods: The rat AIS model was established by autologous blood emboli. Two weeks before surgery, rats were pretreated with simvastatin (60 mg/kg/d), and three hours after surgery, t-PA (10 mg/kg) was administered. MMP-9 and TIMP-1 levels in the infarcted zone and plasma were evaluated by Western blot analysis and ELISA; the level of HT was quantified by determining the hemoglobin content. RhoA activation was determined to clarify the potential effect.Results: The results suggested that pretreatment with simvastatin suppressed the increase in t-PA-induced MMP-9 levels and neutralized the elevated MMP-9/TIMP-1 ratio, but had no effect on TIMP-1 levels. Thrombolysis with t-PA after ischemia improved neurological outcome, but increased intracranial hemorrhage. Moreover, t-PA-induced HT aggravation was reduced by simvastatin pretreatment. In addition, we showed that t-PA-induced activation of RhoA was suppressed by simvastatin, and that t-PA-induced MMP-9/TIMP-1 imbalance and hemorrhage was reduced by Rho kinases (ROCK) inhibitor Y-27632.Conclusion: In this study, we showed that simvastatin pretreatment ameliorated t-PA-induced HT and MMP-9/TIMP-1 imbalance, and demonstrated that the RhoA/ROCK pathway was implicated.Keywords: simvastatin, acute ischemic stroke, t-PA, MMP-9/TIMP-1, RhoA/ROCK pathway, hemorrhagic transformationhttps://www.dovepress.com/simvastatin-pretreatment-ameliorates-t-pandashinduced-hemorrhage-trans-peer-reviewed-article-NDTsimvastatinacute ischemic stroket-PAMMP-9/TIMP-1Rho/ROCK pathwayhemorrhagic transformation
spellingShingle Yin B
Li DD
Xu SY
Huang H
Lin J
Sheng HS
Fang JH
Song JN
Zhang M
Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
Neuropsychiatric Disease and Treatment
simvastatin
acute ischemic stroke
t-PA
MMP-9/TIMP-1
Rho/ROCK pathway
hemorrhagic transformation
title Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
title_full Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
title_fullStr Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
title_full_unstemmed Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
title_short Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
title_sort simvastatin pretreatment ameliorates t pa ndash induced hemorrhage transformation and mmp 9 timp 1 imbalance in thromboembolic cerebral ischemic rats
topic simvastatin
acute ischemic stroke
t-PA
MMP-9/TIMP-1
Rho/ROCK pathway
hemorrhagic transformation
url https://www.dovepress.com/simvastatin-pretreatment-ameliorates-t-pandashinduced-hemorrhage-trans-peer-reviewed-article-NDT
work_keys_str_mv AT yinb simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT lidd simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT xusy simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT huangh simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT linj simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT shenghs simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT fangjh simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT songjn simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats
AT zhangm simvastatinpretreatmentamelioratestpandashinducedhemorrhagetransformationandmmp9timp1imbalanceinthromboemboliccerebralischemicrats